MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10120-025-01669-9

Медицинская библиотека · Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025

COPS5 inhibition synergizes with the antitumor effect of trastuzumab by PTEN upregulation in HER2-amplified gastric cancer.

Hwang Sung-Hyun, Kim Ji-Won, Park Haeseong, Aguirre Andrew J, Kim Kui-Jin, Choi Songji, Park Woochan, Seo Jeongmin, Chae Heejung, Kang Minsu, Jung Eun Hee, Suh Koung Jin, Kim Se Hyun, Kim Jin Won, Kim Yu Jung, Kim Jee Hyun, Lee Keun-Wook

СтатьяПоддержка исследования: вне правительства СШАПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

BACKGROUND

COP9 Signalosome Subunit 5 (COPS5) is a deubiquitinating enzyme that induces chemotherapy resistance. The role of COPS5 amplification in patients with gastric cancer (GC) and its therapeutic potential in HER2-amplified GC models have not been explored.

METHODS

The Cancer Genome Atlas (TCGA) data were analyzed to assess the clinical relevance of COPS5 amplification in patients with GC. Functional studies using HER2-amplified GC cell lines and xenograft models evaluated the effects of COPS5 inhibition (CSN5i-3), alone or in combination with trastuzumab.

RESULTS

In the curated stomach adenocarcinoma cohort (n = 294) from TCGA datasets, COPS5 amplification was significantly more frequent in patients with HER2 amplification (10.5% vs. 2.7%, P = 0.040) and was associated with worse disease-free survival after surgery (median 12.6 vs. 45.2 months, P = 0.012) and overall survival (median 21.4 months vs. not reached, P = 0.004). In HER2-amplified GC cell lines, CSN5i-3 treatment synergized with the antiproliferative effect of trastuzumab. Mechanistically, COPS5 knockout enhanced PTEN expression by ubiquitin-mediated SNAIL degradation, suppressing the AKT downstream pathway. The combination effect was dependent on PTEN expression. Accordingly, COPS5 knockout enhanced the efficacy of AKT inhibitors. In a xenograft model, the combination of CSN5i-3 and trastuzumab demonstrated synergistic antitumor effects compared to monotherapy.

CONCLUSIONS

COPS5 amplification was significantly more prevalent in patients with HER2 amplification and was associated with poor outcomes after surgery. The synergistic antiproliferative effect of COPS5 inhibition and trastuzumab was attributed to increased PTEN expression via SNAIL ubiquitination, resulting in the inhibition of the AKT pathway, warranting further clinical studies in patients with HER2-positive GC.

Для цитирования: Hwang Sung-Hyun, Kim Ji-Won, Park Haeseong, Aguirre Andrew J, Kim Kui-Jin, Choi Songji, Park Woochan, Seo Jeongmin, Chae Heejung, Kang Minsu, Jung Eun Hee, Suh Koung Jin, Kim Se Hyun, Kim Jin Won, Kim Yu Jung, Kim Jee Hyun, Lee Keun-Wook. COPS5 inhibition synergizes with the antitumor effect of trastuzumab by PTEN upregulation in HER2-amplified gastric cancer.. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2025. DOI: 10.1007/s10120-025-01669-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.